Table 3.
Schedule of assessments
| Assessment | Time | ||
| Screening | Baseline (T0) | Postintervention (T1) | |
| CFQ | x | x | x |
| WSAS | x | x | |
| PHQ-9 | x | x | |
| GAD-7 | x | x | |
| PSQI | x | x | |
| BIPQ | x | x | |
| CBSQ | x | x | |
| SHI | x | x | |
| IPAQ-short | x | x | |
| CCI | x | ||
| Sociodemographic characteristics | x | x | |
| Clinical characteristics | x | x | |
| Biochemical outcomes | x | x | |
| Self-reported adverse events | x | ||
| Self-reported treatments for distress or fatigue during study | x | ||
| Qualitative interviews | x | ||
BIPQ, Brief Illness Perceptions Questionnaire; CBSQ, Cognitive and Behavioural Responses to Symptoms Questionnaire; CCI, Charlson Comorbidity Index; CFQ, Chalder Fatigue Questionnaire; GAD-7, Generalised Anxiety Disorder-7; IPAQ-short, International Physical Activity Questionnaire -short form; PHQ-9, Patient Health Questionnaire-9; PSQI, Pittsburgh Sleep Quality Index; SHI, Sleep Hygiene Index; WSAS, Work and Social Adjustment Scale.